Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine*
Depression is treated by a great variety of antidepressant treatments. SSRIs (such as fluoxetine) are well known: it is, however, sure that further progress is needed and the search for antidepressants with other mechanisms of action (such as tianeptine) or different efficacy is still of interest. A multinational study compared tianeptine with fluoxetine in 387 patients with Depressive Episode, or Recurrent Depressive Disorder, or Bipolar Affective Disorder (ICD-10), in a double-blind parallel group design. They were treated for six weeks. At inclusion, no significant difference between groups was shown. Final MADRS scores were 15.7 and 15.8 with tianeptine and fluoxetine, respectively (ITT population) (p = 0.944). MADRS responders were 58% and 56% with tianeptine and fluoxetine, respectively (p = 0.710). No statistical difference was observed for the other efficacy parameters. Thirty-six withdrawals occurred in each group, without any difference for the reasons of discontinuation. There was no major difference between groups for the other safety parameters. In this study, both tianeptine and fluoxetine exhibited a good efficacy and safety. Copyright 1999 Elsevier Science B. V. All rights reserved.
Lôo
H.
H
Service Hospitalo-universitaire de Santé Mentale et de Thérapeutique. Sainte-Anne Hospital, Paris Cedex 14, France.
Saiz-Ruiz
J.
J
Costa E Silva
J. A.
JA
Ansseau
M.
M
Herrington
R.
R
Vaz-Serra
A.
A
Dilling
H.
H
De Risio
S.
S